Home › Prostate Cancer › Arkansas › Springdale
Prostate Cancer clinical trials in Springdale, AR
3 studies for Prostate Cancer are looking for participants at sites in and around Springdale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
RecruitingPhase 3
- Research Site, Springdale
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RecruitingPhase 3
- Highlands Oncology Group, PA, Springdale
- Highlands Oncology Group, PA, Rogers · 10 mi away
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RecruitingPhase 3
- Highlands Oncology Group, Springdale
- Highlands Oncology Group - Rogers, Rogers · 10 mi away
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Springdale
- Non-Small Cell Lung Cancer15 studies
- Schizophrenia8 studies
- Metastatic Cancer6 studies
- Lung Cancer6 studies
- Breast Cancer5 studies
- Cancer (all types)5 studies
- Colorectal Cancer5 studies
- Bladder Cancer4 studies
- Ovarian Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Multiple Myeloma3 studies
- Small Cell Lung Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.